Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society - 1 Dec 2005

Höybye Charlotte, Hilding Agneta, Marcus Claude, Thorén Marja

Abstract excerpt

Prader-Willi syndrome (PWS) is a complex genetic disease, clinically characterised by short stature, abnormal body composition, with more body fat than lean body mass, hyperphagia and obesity. Partial growth hormone (GH) deficiency is common, and GH treatment to PWS children and adults has shown beneficial effects on body composition. In this study, we have evaluated indices of GH's lipolytic effect in 6 PWS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycerol
Share to Human Growth Hormone

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypogonadism

Share to Lactates

Share to Lactic Acid

Share to Lipolysis

Share to Microdialysis

Share to Prader-Willi Syndrome

Source

Identifiers

PMID: 16230042
DOI: 10.1016/j.ghir.2005.08.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.PMID 16230042Read ↗

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.Semantic proximity Read ↗

Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion.Semantic proximity Read ↗

The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.Semantic proximity Read ↗

Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes.Semantic proximity Read ↗

Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome.Semantic proximity Read ↗

Sudden death in Prader-Willi syndrome during growth hormone therapy.Semantic proximity Read ↗

Abnormal metabolic phenotype in middle-aged GH-deficient adults despite long-term recombinant human GH replacement.Semantic proximity Read ↗

Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.Semantic proximity Read ↗

Growth hormone therapy transiently increases apolipoprotein(a) in short beta-thalassaemia major children with normal growth hormone reserve.Semantic proximity Read ↗

The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient PatientsSemantic proximity Read ↗

Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.Semantic proximity Read ↗

Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.